Loading...
•
Dec 31, 2023
Mesa Labs Q3 2024 Earnings Report
Mesa Labs reported a decrease in revenue due to core organic revenue decline, but profitability was supported by the GKE acquisition and improvements in Calibration Solutions.
Key Takeaways
Mesa Labs reported a 1.5% decrease in revenue compared to the third quarter of fiscal year 2023, primarily due to a 9.0% core organic revenue decline, which was partially offset by revenue from the GKE acquisition. Non-GAAP adjusted operating income decreased by 6.8% year-over-year but increased sequentially, driven by the GKE acquisition. Gross profit percentage increased due to the GKE acquisition and improvements in the Calibration Solutions division.
Revenues decreased by 1.5% compared to Q3 2023, primarily due to a 9.0% core organic revenue decline.
The GKE acquisition contributed $3,837 to revenues and helped offset the organic revenue decline.
Non-GAAP adjusted operating income decreased by 6.8% year-over-year but increased sequentially, driven by the GKE acquisition.
Gross profit percentage increased due to the GKE acquisition and improvements in the Calibration Solutions division.
Mesa Labs
Mesa Labs
Mesa Labs Revenue by Segment
Revenue by Segment
Sterilization & Disinfection Control Revenue
CapyFin.comBiopharmaceutical Development Revenue
CapyFin.comCalibration Solutions Revenue
CapyFin.comClinical Genomics Revenue
CapyFin.com Forward Guidance
With ongoing economic uncertainty, Mesa Labs will be conservative in deploying any increases in operating expenses.
Revenue & Expenses
Visualization of income flow from segment revenue to net income